Analysis

Pharma Technology Focus – Issue 60

Pharma Technology Focus – Issue 60

Counting the cost of failure in drug development

Counting the cost of failure in drug development

Could a temperature-resistant vaccine spell the end for rabies and yellow fever?

Could a temperature-resistant vaccine spell the end for rabies and yellow fever?

May's top stories: Thermo Fisher Scientific buys Patheon for $7.2bn, AstraZeneca to sell rights for Seloken

May's top stories: Thermo Fisher Scientific buys Patheon for $7.2bn, AstraZeneca to sell rights for Seloken

Pooling resources for clinical trials

Pooling resources for clinical trials

Are cheap Canadian drugs a solution to US pricing issues?

Are cheap Canadian drugs a solution to US pricing issues?

BlueRock: Canada’s stem cell contender on the journey from petri dish to clinical trial

BlueRock: Canada’s stem cell contender on the journey from petri dish to clinical trial

Micro-machines: nanotech offers new possibilities for disease detection and drug delivery

Micro-machines: nanotech offers new possibilities for disease detection and drug delivery

Pharma Technology Focus – Issue 59

Pharma Technology Focus – Issue 59

Challenging the link between pharma innovation and US drug pricing

Challenging the link between pharma innovation and US drug pricing

Brain boosters: exploring the grey area of off-label ‘smart drugs’

Brain boosters: exploring the grey area of off-label ‘smart drugs’

Crowdfunding for cancer therapy

Crowdfunding for cancer therapy

April's top stories: CN Bio licenced Hepatitis B drug programme, Astellas agreed to acquire Ogeda for €800m

April's top stories: CN Bio licenced Hepatitis B drug programme, Astellas agreed to acquire Ogeda for €800m

Narrowing the hunt for nanoparticles

Narrowing the hunt for nanoparticles

Pharma Technology Focus – Issue 58

Pharma Technology Focus – Issue 58

Pharmaceutical packaging: where should drug companies focus their efforts?

Pharmaceutical packaging: where should drug companies focus their efforts?

Alzheimer’s drugs: will 2017 bring better news?

Alzheimer’s drugs: will 2017 bring better news?

March's top stories: Perrigo's $2.85bn sale, Cancer Research UK's Precision Panc project

March's top stories: Perrigo's $2.85bn sale, Cancer Research UK's Precision Panc project

Cancergraph: a desperately needed link between patient and clinical trial

Cancergraph: a desperately needed link between patient and clinical trial

Illuminating drug discovery by mapping all known drugs

Illuminating drug discovery by mapping all known drugs

Pharma Technology Focus – Issue 57

Pharma Technology Focus – Issue 57
cachename:Featurescachekey:rd-1665407042_727740091_rd-488908060_1460672566_ap1460672566_727740091_1125324024